John Stewart, MD, MBA, FACS 

Education

POSTGRADUATE:
National Institutes of Health
Fellowships: Tumor Immunotherapy & Surgical Oncology 

Vanderbilt University
Residency: General Surgery

Temple University School of Medicine
Residency: General Surgery

GRADUATE:
Wake Forest University
Degree: Master’s in Business Administration

MEDICAL SCHOOL:
Howard University College of Medicine
Degree: MD

UNDERGRADUATE:
Louisiana Tech University
Degree: BS in Zoology (Honors)

Research Interests

• Developmental Oncoimmunotherapeutics Surgical Oncology
• Clinical Trials Artificial Intelligence in Healthcare Delivery of Cancer Therapy to Underserved Populations Healthcare
• Finance Healthcare Policy Healthcare Strategy Healthcare Operations

Specialties

• Surgical Oncology

Board Certification

• American Board of Surgery

Publications

• Shen P, Stewart JH 4^th, Levine EA. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Overview and Rationale. Current Problems in Cancer, 33(3):125-41, May-Jun 2009.
• Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, Levine EA. Management of Peritoneal Carcinomatosis from Colorectal Cancer. Seminars in Oncology, 38(4):468-75, Aug 2011.
• Stewart JH, Levine Role of bacillus Calmette-Guérin in the treatment of advanced melanoma. Expert Rev Anticancer Ther, 11(11):1671-6, Nov 2011.
• Newman NA, Votanopoulos KI, Stewart JH, Shen P, Levine EA. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer. Minerva Chir, 67(4):309-318, Aug 2012.
• Votanopoulos KI, Shen P, Stewart JH 4th, Levine EA. Current status and future directions in appendiceal cancer with peritoneal dissemination. Surg Oncol Clin N Am, 21(4):599-609, Oct 2012. doi: 10.1016/j.soc.2012.07.012.
• Johnston FM, Yeo HL, Clark C, Stewart JH Bias Issues in Colorectal Cancer Management: A Review. Ann Surg Oncol. 2022 Apr;29(4):2166-2173. doi:10.1245/s10434-021-10232-6.
• Kumar V, Stewart JH 4th. Immunometabolic Reprogramming, Another Cancer Hallmark. Frontiers in Immunology. 2023 May 19;14:1125874. doi:10.3389/fimmu.2023.1125874. PMID: 37275901; PMCID: PMC10235624.
• Kumar V, Bauer C, Stewart JH 4th. Targeting cGAS/STING Signaling-mediated Myeloid Immune Cell Dysfunction in TIME. Journal of Biomedical Sciences. 2023 Jun 28;30(1):48.doi: 10.1186/s12929-023-00942-2. PMID: 37380989; PMCID: PMC10304357.
• Kumar V, Bauer C, Stewart JH 4th. TIME Is Ticking for Cervical Cancer. Biology (Basel). 2023 Jun 30;12(7):941. doi: 10.3390/biology12070941. PMID:37508372; PMCID: PMC10376148.
• Kumar V, Stewart JH 4th. Editorial: Immunology of cachexia. Front Immunol. 2023 Dec 5;14:1339263. doi: 10.3389/fimmu.2023.1339263. PMID: 38116001; PMCID:PMC10728869.
• Kumar V, Stewart JH 4th. Obesity, bone marrow adiposity, and leukemia: Time to act. Obes Rev. 2023 Dec 13:e13674. doi: 10.1111/obr.13674. Epub ahead of print. PMID:38092420.

Honors and Awards

• 2023: Howard University College of Medicine Distinguished Alumni Award
• 2018 - 2022: Presidential Scholar, University of Illinois
• 2015: Hooding Ceremony Speaker, Howard University College of Medicine
• 2013 - 2015: NCI Cancer Clinical Investigator Team Leadership Award
• 2012 - 2015: Best Doctors in America
• 2012 - 2014: Wells Fargo Scholar, Babcock School of Management
• 2011 - 2015: US News and World Report Top Doctors Award